The emerging treatment of the medication represents a major breakthrough in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets dual pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide150783.designertoblog.com/73490112/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment